Bill Bulman
Medical Director, Pulmonology Veracyte
Seminars
Tuesday 21st July 2026
Leveraging Whole Genome Sequencing Using the TrueMRD Platform for Precision Cancer Monitoring
3:40 pm
- The TrueMRD Platform uses whole-genome sequencing on primary baseline and every subsequent sample
- A.I. model analyzes thousands of genomic signals to create a patient-specific signature
- The TrueMRD Platform enables monitoring of patient-specific cancer evolution over time
